Boston Biomedical Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.63B

Boston Biomedical General Information

Description

Developer of novel cancer therapeutics intended to significantly improve patient outcomes. The company's range of expertise includes drug discovery, external innovation partnerships, medicinal chemistry, preclinical development, pharmacology, pharmaceutical development, CMC (chemistry, manufacturing, and control), global clinical trials, regulatory affairs, and commercialization, enabling physicians to access novel therapeutics for patients with cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 640 Memorial Drive
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 640 Memorial Drive
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boston Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 25-Apr-2012 $2.63B Completed Clinical Trials - General
1. Early Stage VC (Series A) 15-Jun-2010 Completed Product Development
To view Boston Biomedical’s complete valuation and funding history, request access »

Boston Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Boston Biomedical’s complete cap table history, request access »

Boston Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel cancer therapeutics intended to significantly improve patient outcomes. The company's range of expert
Drug Discovery
Cambridge, MA
30 As of 2012

Maastricht, Netherlands
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Boston Biomedical Competitors (51)

One of Boston Biomedical’s 51 competitors is Cristal Therapeutics, a Venture Capital-Backed company based in Maastricht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
CTI BioPharma Formerly VC-backed Seattle, WA
Apexian Pharmaceuticals Venture Capital-Backed Indianapolis, IN
You’re viewing 5 of 51 competitors. Get the full list »

Boston Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boston Biomedical Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mitsui Global Investment Venture Capital Minority
To view Boston Biomedical’s complete investors history, request access »

Boston Biomedical FAQs

  • When was Boston Biomedical founded?

    Boston Biomedical was founded in 2006.

  • Where is Boston Biomedical headquartered?

    Boston Biomedical is headquartered in Cambridge, MA.

  • What is the size of Boston Biomedical?

    Boston Biomedical has 30 total employees.

  • What industry is Boston Biomedical in?

    Boston Biomedical’s primary industry is Drug Discovery.

  • Is Boston Biomedical a private or public company?

    Boston Biomedical is a Private company.

  • What is the current valuation of Boston Biomedical?

    The current valuation of Boston Biomedical is .

  • What is Boston Biomedical’s current revenue?

    The current revenue for Boston Biomedical is .

  • How much funding has Boston Biomedical raised over time?

    Boston Biomedical has raised $3M.

  • Who are Boston Biomedical’s investors?

    Mitsui Global Investment has invested in Boston Biomedical.

  • Who are Boston Biomedical’s competitors?

    Cristal Therapeutics, CytomX Therapeutics, Intellia Therapeutics, CTI BioPharma, and Apexian Pharmaceuticals are some of the 51 competitors of Boston Biomedical.

  • When was Boston Biomedical acquired?

    Boston Biomedical was acquired on 25-Apr-2012.

  • Who acquired Boston Biomedical?

    Boston Biomedical was acquired by Sumitomo Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process